Who is most likely to have money problems during cancer?

Anyone can be, but the risk clusters. It falls hardest on people with advanced cancer or cancer that came back. It falls hard on people diagnosed young, on people with lower household income, on people who lose a job, and on people with no insurance.

The National Cancer Institute calls this financial toxicity. It means money problems caused by the cost of medical care. You see it in copayments, deductibles, and coinsurance. It is common. Cancer survivors as a group report higher out-of-pocket spending than people who never had cancer.

The disease and treatment side

Risk is higher with advanced cancer, or cancer that has come back, or cancer with a poor outlook. It is higher with more than one type of cancer. It is higher when another long-term illness, such as heart disease or diabetes, sits alongside the cancer. Part of the reason is simple. Those situations often stop a person from working.

Treatment matters too. People treated with both chemotherapy and radiation therapy carry higher out-of-pocket costs than people who had neither.

Age, income, and work

Younger age at diagnosis raises risk, which surprises people. NCI gives three reasons. Younger adults have had less time to build savings. They often carry other duties, such as raising children. And they cannot get Medicare before 65, so they may have no insurance, or a high-deductible plan with heavy costs.

Survivors of childhood cancer carry a version of this into adult life. A diagnosis in childhood can interrupt school and narrow job options. Those survivors also face higher out-of-pocket costs than their own siblings. Second cancers and lasting effects of treatment are the reason.

Lower household income raises risk. Losing a job has been shown to lead to debt and bankruptcy. Some studies find that people in racial and ethnic minority groups are more likely to have money problems after a cancer diagnosis. NCI notes that more research is needed there.

The work effects can be counted. One study found that people working while getting cancer treatment missed about 22 more workdays a year than people not in treatment. Missed days are only part of it. People also report losing a job, dropping to part-time, taking long leave, struggling to return, and earning less.

Insurance helps, but it is not immunity

Having no health insurance means high risk, especially as costs rise. But NCI is blunt that insurance does not settle the question. Premiums, copayments, deductibles, and coinsurance have all climbed. Newer chemotherapy and immunotherapy drugs cost more than what was standard ten years ago. Copays for brand-name drugs can also rise over time.

One study found people on public insurance, meaning Medicaid or Medicare, had higher risk than people on private plans. Part of the reason is that they tend to have fewer savings to fall back on. If you are on Medicare, two things can lower what you pay: supplemental insurance and a Part D drug plan.

Your own household picture matters as much as your plan. Are you the main earner? What do others in your home earn? How much debt did you carry before the diagnosis? What do you own, and do you have disability insurance? All of it feeds in.

What it actually costs people

Some cancer survivors report spending more than 20% of their annual income on medical care.

The knock-on effects are documented. Unpaid bills. Past-due mortgage payments. Foreclosures and repossessions. Debt and bankruptcy. To cope, people draw down savings, borrow money, and cut spending on food, clothing, and utilities. Some sell possessions or property. Some move to cheaper housing.

Caregivers absorb part of it. Family and friends who provide care spend their own money on food, medicine, and other needs. They often take time off work. That raises their sense of burden and worsens their own mental health.

If several of these describe you, talk to a hospital social worker or financial navigator now. Doing it while there is room to act beats doing it after a bill goes to collections. This is a known feature of cancer care in the United States, not a personal failing.

Sources

https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-pdq

https://www.cancer.gov/about-cancer/managing-care/track-care-costs